A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
The deal puts an end to Fubo’s ongoing lawsuit that sought to block Disney’s efforts to build Venu Sports with Fox and Warner Bros. Discovery.
Record earnings from Foxconn and some fresh tariff news highlight core themes likely to dominate headlines this year.
People who work on Wall Street face a more quotidian challenge starting this morning: getting there, thanks to New York’s congestion pricing.